This patent is for nanophotovoltaic devices formed from silicon or gallium arsenide having sizes in a range of about 50 nanometers to about 5 microns, and method of their fabrication.
Although there are a number of applications, the patent describes one application which is to inject nanophotovoltaic devices into diseased tissue, e.g., cancerous tissue, and activate these cells by the use of suitable radiation. These cells will generate electric fields in the tissue, causing a disruption of the cancerous cells.
Another day, another neat Solar Tech Announcement.
Spire is an interesting company. They don't seem to get much notice, but they've been around for a very long time. The present CEO, Roger G. Little, founded the company in 1969. He's a Physicist / Ironman Triathlete, and is surely tough as nails by the fact that he's stuck with a business like Solar Energy for so long; through so many years of very unfriendly market conditions. In addition to Solar, Spire has several Medical and Semiconductor Technologies that they produce, and so this new patent seems like a nice little fit between the several divisions of the Company.